Interview

Alan Leong, Director of Research for NymbleInvestor.com, and David Miller, NymbleInvestor.com's President, interview Dendreon (NASDAQ:DNDN) President Dr. David Urdal about the business of cancer vaccines as well as Dendreon's products, operations, and future prospects.

Thank you for your interest in this interview. We have moved it to our new site at BiotechMonthly.com. When you visit our new site, click on "Interviews." You'll be looking near the bottom of that page for the link to this interview.

Entire site and contents © 1999-2001 Nymble Investments. All rights reserved.

For the use of authorized users according to

the Terms and Conditions. Unauthorized distribution of these pages

or their contents is a violation of state and federal copyright law.